Inhaled bronchodilators for cystic fibrosis-Reference-Cited by-同舟云学术

Inhaled bronchodilators for cystic fibrosis

Published:2016-02-11 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Halfhide Clare¹,Evans Hazel J²,Couriel Jon¹

Affiliation:

1. Alder Hey Children's NHS Foundation Trust; Respiratory Unit; Eaton Road Liverpool Merseyside UK L12 2AP

2. Southampton University Hospitals Trust; Department of Respiratory Paediatrics; Tremona Road Southampton UK SO16 6YD

Publisher

Wiley

Subject

Pharmacology (medical)

Reference77 articles.

1. Efficacy of salbutamol and ipratropium bromide in decreasing bronchial hyperreactivity in children with cystic fibrosis;Avital;Pediatric Pulmonolgy,1992

2. The effects of inhaled B2 agonists on maximal exercise in patients with cystic fibrosis [abstract];Dodd;American Journal of Respiratory and Critical Care Medicine,2001

3. Inhaled beta-agonists improve lung function but not maximal exercise capacity in cystic fibrosis;Dodd;Journal of Cystic Fibrosis,2005

4. The use of bronchodilators as an adjunct to physiotherapy in adults with cystic fibrosis [abstract];Duncan,1982

5. The use of bronchodilators as an adjunct to physiotherapy in adults with cystic fibrosis [abstract];Duncan,1982

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Short-acting inhaled bronchodilators for cystic fibrosis;Cochrane Database of Systematic Reviews;2022-06-24

2. Treatment of Pulmonary Disease of Cystic Fibrosis: A Comprehensive Review;Antibiotics;2021-04-23

3. Nanomedicine Approaches for the Pulmonary Treatment of Cystic Fibrosis;Frontiers in Bioengineering and Biotechnology;2019-12-17